Clinical association of metabolic syndrome, C‐reactive protein and testosterone levels with clinically significant prostate cancer

Recently, the influence that metabolic syndrome (MetS), hormonal alterations and inflammation might have on prostate cancer (PCa) risk has been a subject of controversial debate. Herein, we aimed to investigate the association between MetS‐components, C‐reactive protein (CRP) and testosterone levels...

Descripción completa

Detalles Bibliográficos
Autores principales: Gómez‐Gómez, Enrique, Carrasco‐Valiente, Julia, Campos‐Hernández, Juan Pablo, Blanca‐Pedregosa, Ana Maria, Jiménez‐Vacas, Juan Manuel, Ruiz‐García, Jesus, Valero‐Rosa, Jose, Luque, Raul Miguel, Requena‐Tapia, María José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349154/
https://www.ncbi.nlm.nih.gov/pubmed/30450757
http://dx.doi.org/10.1111/jcmm.13994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349154/
https://www.ncbi.nlm.nih.gov/pubmed/30450757
http://dx.doi.org/10.1111/jcmm.13994

Ejemplares similares